サマリー

世界の女性用避妊薬市場 2023-2027
Technavioは女性用避妊薬市場を監視しており、2023年から2027年の間に5億1422万ドルの成長が見込まれ、予測期間中にCAGR 5.32%で加速しています。当レポートでは、女性用避妊薬市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、革新的なマーケティング戦略の採用の増加、消費者の視点の進化、様々な避妊方法の利用可能性などによって牽引されています。
Technavioの女性用避妊具市場は以下のように区分されています。
流通チャネル別
- オフライン
- オンライン
製品別
- 女性用避妊具
- 女性用避妊薬
地域別
- 北アメリカ
- 欧州
- APAC
- 南米
- 中東・アフリカ
本調査では、今後数年間における女性用避妊具市場の成長を促進する主な理由の一つとして、女性用コンドームの人気の高まりを挙げています。また、IUSの技術的進歩やeコマースプラットフォームの高成長は、市場の相当な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。女性用避妊薬市場に関する弊社のレポートは、以下の分野を対象としています。
- 女性用避妊薬市場のサイジング
- 女性用避妊薬市場の予測
- 女性用避妊薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Afaxys Pharma LLC、Agile Therapeutics Inc、Amgen Inc、Ansell Ltd、Bayer AG、CooperSurgical Inc、Cupid Ltd、Exeltis USA Inc、Johnson and Johnson、Mayer Laboratories Inc、Medisafe Distribution Inc.を含む複数の主要女性避妊薬市場ベンダーに関する詳細分析を提供しています。Inc、Mylan NV、Pfizer Inc、Piramal Enterprises Ltd、Reckitt Benckiser Group PLC、Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、およびVeru Inc.が含まれます。また、女性用避妊薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/female-contraceptive-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括することで、市場の詳細なイメージを提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、広範な一次および二次調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global female contraceptive market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global female contraceptive market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Offline - Market size and forecast 2022-2027
o Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 6.4 Online - Market size and forecast 2022-2027
o Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 43: Chart on Product - Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 45: Chart on Comparison by Product
o Exhibit 46: Data Table on Comparison by Product
o 7.3 Female contraceptive devices - Market size and forecast 2022-2027
o Exhibit 47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
o 7.4 Female contraceptive drugs - Market size and forecast 2022-2027
o Exhibit 51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 55: Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 APAC - Market size and forecast 2022-2027
o Exhibit 69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on APAC - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
o 9.6 South America - Market size and forecast 2022-2027
o Exhibit 73: Chart on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on South America - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on South America - Year-over-year growth 2022-2027 (%)
o 9.7 Middle East and Africa - Market size and forecast 2022-2027
o Exhibit 77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o 9.8 US - Market size and forecast 2022-2027
o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Japan - Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 108: AbbVie Inc. - Overview
o Exhibit 109: AbbVie Inc. - Product / Service
o Exhibit 110: AbbVie Inc. - Key offerings
o 12.4 Afaxys Pharma LLC
o Exhibit 111: Afaxys Pharma LLC - Overview
o Exhibit 112: Afaxys Pharma LLC - Product / Service
o Exhibit 113: Afaxys Pharma LLC - Key offerings
o 12.5 Agile Therapeutics Inc.
o Exhibit 114: Agile Therapeutics Inc. - Overview
o Exhibit 115: Agile Therapeutics Inc. - Product / Service
o Exhibit 116: Agile Therapeutics Inc. - Key offerings
o 12.6 Ansell Ltd.
o Exhibit 117: Ansell Ltd. - Overview
o Exhibit 118: Ansell Ltd. - Business segments
o Exhibit 119: Ansell Ltd. - Key news
o Exhibit 120: Ansell Ltd. - Key offerings
o Exhibit 121: Ansell Ltd. - Segment focus
o 12.7 Bayer AG
o Exhibit 122: Bayer AG - Overview
o Exhibit 123: Bayer AG - Business segments
o Exhibit 124: Bayer AG - Key offerings
o Exhibit 125: Bayer AG - Segment focus
o 12.8 CooperSurgical Inc.
o Exhibit 126: CooperSurgical Inc. - Overview
o Exhibit 127: CooperSurgical Inc. - Product / Service
o Exhibit 128: CooperSurgical Inc. - Key offerings
o 12.9 Cupid Ltd.
o Exhibit 129: Cupid Ltd. - Overview
o Exhibit 130: Cupid Ltd. - Product / Service
o Exhibit 131: Cupid Ltd. - Key offerings
o 12.10 Johnson and Johnson
o Exhibit 132: Johnson and Johnson - Overview
o Exhibit 133: Johnson and Johnson - Business segments
o Exhibit 134: Johnson and Johnson - Key news
o Exhibit 135: Johnson and Johnson - Key offerings
o Exhibit 136: Johnson and Johnson - Segment focus
o 12.11 Mayer Laboratories Inc.
o Exhibit 137: Mayer Laboratories Inc. - Overview
o Exhibit 138: Mayer Laboratories Inc. - Product / Service
o Exhibit 139: Mayer Laboratories Inc. - Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 140: Merck and Co. Inc. - Overview
o Exhibit 141: Merck and Co. Inc. - Business segments
o Exhibit 142: Merck and Co. Inc. - Key news
o Exhibit 143: Merck and Co. Inc. - Key offerings
o Exhibit 144: Merck and Co. Inc. - Segment focus
o 12.13 Mylan NV
o Exhibit 145: Mylan NV - Overview
o Exhibit 146: Mylan NV - Business segments
o Exhibit 147: Mylan NV - Key offerings
o Exhibit 148: Mylan NV - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 149: Pfizer Inc. - Overview
o Exhibit 150: Pfizer Inc. - Product / Service
o Exhibit 151: Pfizer Inc. - Key news
o Exhibit 152: Pfizer Inc. - Key offerings
o 12.15 Reckitt Benckiser Group PLC
o Exhibit 153: Reckitt Benckiser Group PLC - Overview
o Exhibit 154: Reckitt Benckiser Group PLC - Business segments
o Exhibit 155: Reckitt Benckiser Group PLC - Key offerings
o Exhibit 156: Reckitt Benckiser Group PLC - Segment focus
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Veru Inc.
o Exhibit 162: Veru Inc. - Overview
o Exhibit 163: Veru Inc. - Business segments
o Exhibit 164: Veru Inc. - Key offerings
o Exhibit 165: Veru Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global female contraceptive market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Chart on Product - Market share 2022-2027 (%)
Exhibits44: Data Table on Product - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product
Exhibits46: Data Table on Comparison by Product
Exhibits47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AbbVie Inc. - Overview
Exhibits109: AbbVie Inc. - Product / Service
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Afaxys Pharma LLC - Overview
Exhibits112: Afaxys Pharma LLC - Product / Service
Exhibits113: Afaxys Pharma LLC - Key offerings
Exhibits114: Agile Therapeutics Inc. - Overview
Exhibits115: Agile Therapeutics Inc. - Product / Service
Exhibits116: Agile Therapeutics Inc. - Key offerings
Exhibits117: Ansell Ltd. - Overview
Exhibits118: Ansell Ltd. - Business segments
Exhibits119: Ansell Ltd. - Key news
Exhibits120: Ansell Ltd. - Key offerings
Exhibits121: Ansell Ltd. - Segment focus
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key offerings
Exhibits125: Bayer AG - Segment focus
Exhibits126: CooperSurgical Inc. - Overview
Exhibits127: CooperSurgical Inc. - Product / Service
Exhibits128: CooperSurgical Inc. - Key offerings
Exhibits129: Cupid Ltd. - Overview
Exhibits130: Cupid Ltd. - Product / Service
Exhibits131: Cupid Ltd. - Key offerings
Exhibits132: Johnson and Johnson - Overview
Exhibits133: Johnson and Johnson - Business segments
Exhibits134: Johnson and Johnson - Key news
Exhibits135: Johnson and Johnson - Key offerings
Exhibits136: Johnson and Johnson - Segment focus
Exhibits137: Mayer Laboratories Inc. - Overview
Exhibits138: Mayer Laboratories Inc. - Product / Service
Exhibits139: Mayer Laboratories Inc. - Key offerings
Exhibits140: Merck and Co. Inc. - Overview
Exhibits141: Merck and Co. Inc. - Business segments
Exhibits142: Merck and Co. Inc. - Key news
Exhibits143: Merck and Co. Inc. - Key offerings
Exhibits144: Merck and Co. Inc. - Segment focus
Exhibits145: Mylan NV - Overview
Exhibits146: Mylan NV - Business segments
Exhibits147: Mylan NV - Key offerings
Exhibits148: Mylan NV - Segment focus
Exhibits149: Pfizer Inc. - Overview
Exhibits150: Pfizer Inc. - Product / Service
Exhibits151: Pfizer Inc. - Key news
Exhibits152: Pfizer Inc. - Key offerings
Exhibits153: Reckitt Benckiser Group PLC - Overview
Exhibits154: Reckitt Benckiser Group PLC - Business segments
Exhibits155: Reckitt Benckiser Group PLC - Key offerings
Exhibits156: Reckitt Benckiser Group PLC - Segment focus
Exhibits157: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits158: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits159: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits160: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits162: Veru Inc. - Overview
Exhibits163: Veru Inc. - Business segments
Exhibits164: Veru Inc. - Key offerings
Exhibits165: Veru Inc. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations